D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ADCT holding history
ADC Therapeutics SA in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADCT overviewAll 13F holders of ADCTFull Q2 2026 holdings
- Shares (Q2 2026)
- 719,320
- Value
- $769.7K
- % of portfolio
- <0.1%
- Quarters held
- 6
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 719,320 | $769.7K | <0.1% | +476,144+195.8% | Added | Holders |
| Q1 2026 | 243,176 | $911.9K | <0.1% | −19,895−7.6% | Reduced | Holders |
| Q4 2025 | 263,071 | $928.6K | <0.1% | +263,071 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −284,243−100.0% | Sold out | Holders |
| Q3 2024 | 284,243 | $895.4K | <0.1% | +20,531+7.8% | Added | Holders |
| Q2 2024 | 263,712 | $833.3K | <0.1% | +236,791+879.6% | Added | Holders |
| Q1 2024 | 26,921 | $120.9K | <0.1% | +26,921 | New | Holders |